Kinaset Therapeutics

Medfield, US · Founded 2020 · Delaware corporation · 6 known investors

Kinaset Therapeutics is a biopharmaceutical company developing respiratory drug therapies. It is led by a team with respiratory drug development experience and supported by scientific and clinical advisors in the field.

BiotechHealthtechin /kinaset-tx @KinasetT

Founders & leadership

Jamil BegDirector of the Issuer

Tom KingDirector of the Issuer

Roger HeermanChief Business/Operating Officer / Co-Founder

Kevin BittermanDirector of the Issuer

Frazer MorganChief Development Officer / Co-Founder

Bram VanparysDirector of the Issuer

Robert ClarkeChief Executive Officer / Board Member / Co-Founder

Christopher O’BrienChief Medical Officer

Investors · 6

5AM Ventures✓ verifiedBoston · $100K – $4M

Atlas Venture✓ verifiedCambridge · $500K – $1M

RA Capital✓ verifiedBoston

EQT Life Sciences✓ verifiedLuxembourg · $11M – $66M

Sixty Degree CapitalNorth York

Vivo CapitalPalo Alto · $10M – $50M

Reported raises · per SEC filings

Form D private placements

▶$28.5MraisedJul 2023 · 3 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Tom KingDirector
Jamil BegDirector
Robert ClarkeExecutive Officer, Director, Promoter
Bram VanparysDirector
Frazer MorganExecutive Officer, Promoter
Kevin BittermanDirector
Roger HeermanExecutive Officer, Promoter

Offering amount: $41M
Amount sold: $28.5M
Minimum investment: $7.1M
First sale: Jul 2022
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1.5MraisedAug 2020 · 3 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Jamil BegDirector
Tom KingDirector
Roger HeermanExecutive Officer, Promoter
Kevin BittermanDirector
Frazer MorganExecutive Officer, Promoter
Bram VanparysDirector
Robert ClarkeExecutive Officer, Director, Promoter

Offering amount: $40M
Amount sold: $1.5M
Minimum investment: $375K
First sale: Jul 2020
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.